Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
40 studies found for:    " April 09, 2008":" May 09, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Enhancing Communication and HIV Outcomes
Condition: HIV Infections
Intervention: Behavioral: communication training
22 Completed Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)
Conditions: Hepatitis B;   HIV Infection
Intervention: Biological: GenHevac-B
23 Completed CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy
Conditions: HIV Infections;   AIDS
Interventions: Procedure: Upper Endoscopy and biopsies;   Drug: raltegravir;   Drug: efavirenz
24 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
25 Completed An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Condition: HIV Infections
Intervention: Drug: elvucitabine
26 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
27 Completed A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744
Condition: HIV Infection
Intervention: Drug: GSK1265744
28 Completed China Adherence for Life
Condition: HIV Infections
Intervention: Behavioral: Electronic drug monitoring feedback intervention
29 Unknown  Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Intervention:
30 Terminated Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
Conditions: Atherosclerosis;   HIV Infections
Interventions: Drug: Rosuvastatin;   Drug: Placebo
31 Terminated Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Nevirapine
32 Completed Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences
Condition: HIV Infections
Intervention:
33 Active, not recruiting Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Conditions: HIV Infections;   Hyperlipidemia
Intervention: Drug: Atorvastatin
34 Completed Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
35 Suspended Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort
Condition: HIV Infections
Interventions: Drug: Ibandronate;   Behavioral: Lifestyle modifications
36 Completed Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru
Conditions: HIV Infections;   Sexually Transmitted Infections
Interventions: Behavioral: Enhanced Partner Therapy (EPT);   Behavioral: Communidades Positivas (CPOS);   Behavioral: Standard Care
37 Completed The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)
Condition: HIV Infections
Interventions: Drug: Pravastatin;   Drug: Raltegravir;   Drug: Pravastatin and raltegravir
38 Completed Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
Condition: HIV Infections
Interventions: Drug: Vacc-4x;   Drug: Sterile water
39 Completed
Has Results
TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents
Condition: HIV-1
Interventions: Drug: Etravirine (TMC125);   Drug: Optimized background regimen (OBR)
40 Completed
Has Results
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Condition: HIV-1 and Hepatitis C Co-Infection
Interventions: Drug: pioglitazone;   Drug: peginterferon;   Drug: ribavirin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years